Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Other Non-Current Liabilities (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $484000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities fell 36.4% to $484000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $484000.0 through Dec 2025, down 36.4% year-over-year, with the annual reading at $484000.0 for FY2025, 36.4% down from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $484000.0 at Day One Biopharmaceuticals, down from $761000.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $761000.0 in Q4 2024, with the low at $484000.0 in Q4 2025.